Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells

Abstract

Mitochondrial dysfunction is a basic mechanism leading to drug nephrotoxicity. Replacement of defective mitochondria with freshly isolated mitochondria is potentially a comprehensive tool to inhibit cytotoxicity induced by ifosfamide on renal proximal tubular cells (RPTCs). We hypothesize that the direct exposure of freshly isolated mitochondria into RPTCs affected by ifosfamide might restore mitochondrial function and reduce cytotoxicity. So, the aim of this study was to assess the protective effect of freshly isolated mitochondrial transplantation against ifosfamide-induced cytotoxicity in RPTCs. Therefore, the suspension of rat RPTCs (10⁶ cells/ml) in Earle’s solution with the pH of 7.4 at 37°C was incubated for 2 h after ifosfamide (4 mM) addition. Fresh mitochondria were isolated from the rat kidney and diluted to the needed concentrations at 4°C. The media containing suspended RPTCs was replaced with mitochondrial-supplemented media, which was exposed to cells for 4 hours in flasks-rotating in a water bath at 37°C. Statistical analysis demonstrated that mitochondrial administration reduced cytotoxicity, lipid peroxidation (LPO), reactive oxygen species (ROS) production, mitochondrial membrane potential (MMP) collapse, lysosomal membrane damage, extracellular oxidized glutathione (GSSG) level, and caspase-3 activity induced by ifosfamide in rat RPTCs. Moreover, mitochondrial transplantation increased the intracellular reduced glutathione (GSH) level in RPTCs affected by ifosfamide. According to the current study, mitochondrial transplantation is a promising therapeutic method in xenobiotic-caused nephrotoxicity pending successful complementary in vivo and clinical studies.

Key words

Mitochondrial Transplantation - Ifosfamide - Oxidative Stress - Nephrotoxicity.

Publikationsverlauf

Eingereicht: 12. September 2022

Angenommen: 10. Oktober 2022

Artikel online veröffentlicht:
17. November 2022

• References

• 1 Nissim I, Horyn O, Daikhin Y. et al. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res 2006; 66: 7824-7831
• 2 Fleming RA. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 1997; 17: 146s-154ss
• 3 Verma S, Younus J, Stys-Norman D. et al. Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline. Curr Oncol 2007; 14: 144-148
• 4 Voûte PA, van den Berg H, Behrendt H. et al. Ifosfamide in the treatment of pediatric malignancies. Semin Oncol 1996; 23: 8-11
• 5 Wagner T. Ifosfamide clinical pharmacokinetics. Clinical pharmacokinetics 1994; 26: 439-456
• 6 Ensergueix G, Pallet N, Joly D. et al. Ifosfamide nephrotoxicity in adult patients. Clin Kidney J 2020; 13: 660-665
• 7 Han HY, Choi MS, Yoon S. et al. Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney. Int J Mol Sci 2021; 22: 12201
• 8 Skinner R. Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 2003; 41: 190-197
• 9 Nissim I, Weinberg JM. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int 1996; 49: 684-695
• 10 Lind MJ, McGown AT, Hadfield JA. et al. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem Pharmacol 1989; 38: 1835-1840
• 11 Springate J, Taub M. Ifosfamide toxicity in cultured proximal renal tubule cells. Pediatr Nephrol 2007; 22: 358-365
• 12 Katrangi E, D’Souza G, Boddapati SV. et al. Xenogenic transfer of isolated murine mitochondria into human rho0 cells can improve respiratory function. Rejuvenation Res 2007; 10: 561-570
• 13 Clark MA, Shay JW. Mitochondrial transformation of mammalian cells. Nature 1982; 295: 605-607
• 14 Islam MN, Das SR, Emin MT. et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012; 18: 759-765
• 15 Kesner EE, Saada-Reich A, Lorberboum-Galski H. Characteristics of Mitochondrial Transformation into Human Cells. Sci Rep 2016; 6: 26057
• 16 Boom SP, Gribnau FW, Russel FG. Organic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat. J Pharmacol Exp Ther 1992; 263: 445-450
• 17 Schafer JA, Watkins ML, Li L. et al. A simplified method for isolation of large numbers of defined nephron segments. Am J Physiol 1997; 273: F650-F657
• 18 Everse J, Reich RM, Kaplan NO. et al. New instrument for rapid determination of activities of lactate dehydrogenase isoenzymes. Clin Chem 1975; 21: 1277-1281
• 19 Preble JM, Pacak CA, Kondo H. et al. Rapid isolation and purification of mitochondria for transplantation by tissue dissociation and differential filtration. J Vis Exp 2014; e51682
• 20 Shaki F, Hosseini MJ, Ghazi-Khansari M. et al. Toxicity of depleted uranium on isolated rat kidney mitochondria. Biochim Biophys Acta 2012; 1820: 1940-1950
• 21 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 22 Rezaei M, Salimi A, Taghidust M. et al. A comparison of toxicity mechanisms of dust storm particles collected in the southwest of Iran on lung and skin using isolated mitochondria. Toxicological & Environmental Chemistry 2014; 96: 814-830
• 23 Baracca A, Sgarbi G, Solaini G. et al. Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta 2003; 1606: 137-146
• 24 Al Maruf A, O'Brien PJ, Naserzadeh P. et al. Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes. Drug Chem Toxicol 2018; 41: 51-61
• 25 Andersson BS, Aw TY, Jones DP. Mitochondrial transmembrane potential and pH gradient during anoxia. Am J Physiol 1987; 252: C349-C355
• 26 Pourahmad J, Rabiei M, Jokar F. et al. A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite. Toxicology 2005; 206: 449-460
• 27 Beach DC, Giroux E. Inhibition of lipid peroxidation promoted by iron(III) and ascorbate. Arch Biochem Biophys 1992; 297: 258-264
• 28 Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226
• 29 Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96-99
• 30 Bereiter-Hahn J, Vöth M, Mai S. et al. Structural implications of mitochondrial dynamics. Biotechnol J 2008; 3: 765-780
• 31 Meier O, Boucke K, Hammer SV. et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 2002; 158: 1119-1131
• 32 Mahammad S, Parmryd I. Cholesterol depletion using methyl-β-cyclodextrin. Methods in membrane lipids. Springer; 2015. p 91-102
• 33 Lundin A. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol 2000; 305: 346-370
• 34 Hosseini MJ, Shaki F, Ghazi-Khansari M. et al. Toxicity of copper on isolated liver mitochondria: impairment at complexes I, II, and IV leads to increased ROS production. Cell Biochem Biophys 2014; 70: 367-381
• 35 Rieder H, Decker K. Phagocytosis of hepatocyte mitochondria by rat Kupffer cells in vitro. Hoppe Seylers Z Physiol Chem 1984; 365: 175-184
• 36 Fujii F, Nodasaka Y, Nishimura G. et al. Anoxia induces matrix shrinkage accompanied by an increase in light scattering in isolated brain mitochondria. Brain Res 2004; 999: 29-39
• 37 Ulger O, Kubat GB. Therapeutic applications of mitochondrial transplantation. Biochimie 2022; 195: 1-15
• 38 Ho PT, Zimmerman K, Wexler LH. et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer 1995; 76: 2557-2564
• 39 Choucha-Snouber L, Aninat C, Grsicom L. et al. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip. Biotechnol Bioeng 2013; 110: 597-608
• 40 Hanly L, Chen N, Rieder M. et al. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Expert Opin Drug Saf 2009; 8: 155-168
• 41 Connors TA, Cox PJ, Farmer PB. et al. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol 1974; 23: 115-129
• 42 Norpoth K. Studies on the metabolism of isopnosphamide (NSC-109724) in man. Cancer Treat Rep 1976; 60: 437-443